Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 264-273 , March 2010

Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)

  • Csaba Polgár

      Affiliations

    • Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    • Corresponding Author InformationCorresponding author. Address: Department of Radiotherapy, National Institute of Oncology, Ráth György u. 7-9, Budapest H-1122, Hungary.
    • ,
  • Erik Van Limbergen

      Affiliations

    • Department of Radiation Oncology, University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • Richard Pötter

      Affiliations

    • Department of Radiotherapy and Radiobiology, University Hospital AKH Vienna, Vienna, Austria
    • ,
  • György Kovács

      Affiliations

    • University of Lübeck, Interdisciplinary Brachytherapy Unit, Lübeck, Germany
    • ,
  • Alfredo Polo

      Affiliations

    • Department of Radiation Oncology, Ramon y Cajal University Hospital, Madrid, Spain
    • ,
  • Jaroslaw Lyczek

      Affiliations

    • Department of Brachytherapy, Institute Marie Skodlowska-Curie, Center of Oncology, Warsaw, Poland
    • ,
  • Guido Hildebrandt

      Affiliations

    • Department of Radiation Oncology, University Hospital Rostock, Rostock, Germany
    • ,
  • Peter Niehoff

      Affiliations

    • University Hospital S-H, Klinik für Strahlentherapie (Radioonkologie), Kiel, Germany
    • ,
  • Jose Luis Guinot

      Affiliations

    • Department of Radiation Oncology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain
    • ,
  • Ferran Guedea

      Affiliations

    • Department of Radiation Oncology, Institut Catalá d’ Oncologia, Barcelona, Spain
    • ,
  • Bengt Johansson

      Affiliations

    • Department of Oncology, Örebro University Hospital, Örebro, Sweden
    • ,
  • Oliver J. Ott

      Affiliations

    • Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany
    • ,
  • Tibor Major

      Affiliations

    • Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    • ,
  • Vratislav Strnad

      Affiliations

    • Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany
    • ,
  • On behalf of the GEC-ESTRO breast cancer working group

Received 8 October 2009 ,Revised 4 January 2010 ,Accepted 23 January 2010.

References 

  1. Bartelink H, Horiot JC, Poortmans H, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25:3259–3265
  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  4. Morrow M. Rational local therapy for breast cancer. N Engl J Med. 2002;347:1270–1271
  5. Antonucci JV, Wallace M, Goldstein NS, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009;74:447–452
  6. Aristei C, Tarducci R, Palumbo I, et al. Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy. Radiother Oncol. 2009;1:43–47
  7. Arthur DW, Winter K, Kuske RR, et al. A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95–17. Int J Radiat Oncol Biol Phys. 2008;72:467–473
  8. Belkacémi Y, Chauvet MP, Giard S, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol. 2009;90:23–29
  9. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: the initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–462
  10. Cionini L, Marzano S, Pacini P, et al. Iridium implant of the surgical bed as the sole radiotherapeutic treatment after conservative surgery for breast cancer. Radiother Oncol. 1995;35:S1;[Abstract]
  11. Dodwell DJ, Dyker K, Brown J, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol. 2005;17:618–622
  12. Fentiman IS, Poole C, Tong D, et al. Inadequacy of iridium implant as a sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32A:608–611
  13. Fentiman IS, Deshmane V, Tong D, et al. Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol. 2004;71:281–285
  14. Gómez-Iturriaga A, Pina L, Cambeiro M, et al. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy. Brachytherapy. 2008;7:310–315
  15. Johansson B, Karlsson L, Liljegren G, et al. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1–T2 breast cancer: first long time results from a clinical study. Radiother Oncol. 2009;90:30–35
  16. Kaufman SA, DiPetrillo TA, Price LL, et al. Long-term outcome and toxicity in a phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy. 2007;6:286–292
  17. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis, 1, 2 breast cancer. Am J Surg. 2000;180:299–304
  18. Kirby AM, Evans PM, Nerurkar AZ, et al. How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy?. Radiother Oncol. 2009;[Epub ahead of print] PubMed PMID: 19963294
  19. Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91–96
  20. Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results of a randomised trial. Radiother Oncol. 1996;39:223–227
  21. Major T, Fröhlich G, Lövey K, et al. Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. Radiother Oncol. 2009;90:48–55
  22. Mannino M, Yarnold J. Accelerated partial breast irradiation trials: diversity in rationale and design. Radiother Oncol. 2009;91:16–22
  23. Moon SH, Shin KH, Kim TH, et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol. 2009;90:66–73
  24. Nairz O, Sedlmayer F. Accelerated partial breast irradiation as a part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009;[Epub ahead of print] PubMed PMID: 19853317
  25. Niehoff P, Polgár C, Ostertag H, et al. Clinical experience with the MammoSite® radiation therapy system for intracavitary brachytherapy of breast cancer–Results from an iternational phase II trial. Radiother Oncol. 2006;79:316–320
  26. Nose T, Komoike Y, Yoshida K, et al. A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer. 2006;13:289–299
  27. Offersen BV, Overgaard M, Kroman N, et al. Accelerated partial breast irradiation as a part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009;90:1–13
  28. Ott OJ, Hildebrandt G, Pötter R, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German–Austrian multi-centre trial. Radiother Oncol. 2007;82:281–286
  29. Patel RR, Christensen ME, Hodge C, et al. Clinical outcome analysis in “high-risk” versus ”low-risk” patients eligible for National Surgical Adjuvant Breast and Bowel B-39/Radiation Therapy Oncology Group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys. 2008;70:970–973
  30. Perera F, Yu E, Engel J, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57:1239–1246
  31. Polgár C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I–II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–128
  32. Polgár C, Major T, Fodor J, et al. HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  33. Polgár C, Strnad V, Major T. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol. 2005;15:116–122
  34. Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma – 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  35. Polgár C, Major T, Lövey K, et al. Hungarian experience on partial breast irradiation versus whole breast irradiation: 12-year results of a phase II trial and updated results of a randomized study. Brachytherapy. 2008;7:91–92[Abstract]
  36. Polgár C, Major T. Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol. 2009;14:7–24
  37. Póti Z, Nemeskéri C, Fekésházy A, et al. Partial breast irradiation with interstitial 60Co brachytherapy results in frequent grade 3 or 4 toxicity: evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys. 2004;58:1022–1033
  38. Samuel LM, Dewar JA, Preece PE, et al. A pilot study of radical radiotherapy using a perioperative implant following wide local excision for carcinoma of the breast. Breast. 1999;8:95–97
  39. Scanderbeg DJ, Yashar C, Rice R, et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol. 2009;90:36–42
  40. Strauss JB, Dickler A. Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. Radiother Oncol. 2009;91:157–165
  41. Strnad V, Ott OJ, Hildebrandt G, et al. Partial breast irradiation using multicatheter interstitial brachytherapy for early breast cancer: Results of the German–Austrian multicenter Phase II trial. Brachytherapy. 2009;8:107;[Abstract]
  42. Thomas CW, Nichol AM, Park JE, et al. An anthropomorphic phantom study of visualisation of surgical clips for partial breast irradiation (PBI) setup verification. Radiother Oncol. 2009;90:56–59
  43. Van Limbergen E. Accelerated partial breast irradiation with intracavitary balloon brachytherapy may be not as simple as it was supposed to be. Radiother Oncol. 2009;91:147–149
  44. Vicini FA, Antonucci V, Wallace M, et al. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys. 2007;68:341–346
  45. Vicini FA, Arthur DW. Breast brachytherapy: North American experience. Semin Radiat Oncol. 2005;15:108–115
  46. Vicini FA, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112:758–766
  47. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001
  48. Orecchia R, Veronesi U. Intraoperative electrons. Semin Radiat Oncol. 2005;15:76–83
  49. Vaidya JS, Tobias JS, Baum M, et al. TARgeted Intraoperative radiotherapy (TARGIT): An innovative approach to partial-breast irradiation. Semin Radiat Oncol. 2005;15:84–91
  50. Formenti SC. External-beam partial breast irradiation. Semin Radiat Oncol. 2005;15:92–99
  51. Clarke DH, Lé MG, Sarrazin D, et al. Analysis of local regional relapses in patients with early breast cancers treated by excision and radiotherapy. Experience of the Institute Gustave Roussy. Int J Radiat Oncol Biol Phys. 1985;11:137–145
  52. Van Limbergen E, van der Bogaert W, van der Shueuren E, et al. Tumor excision and radiotherapy as primary treatment of breast cancer: analysis of patient and treatment parameters and local control. Radiother Oncol. 1987;8:1–9
  53. Polgár C, Major T, Strnad V, et al. What can we conclude from the results of an out-of-date breast-brachytherapy study?. Int J Radiat Oncol Biol Phys. 2004;60:342–343[Letter]
  54. Vicini F, Arthur D, Polgár C, et al. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, adequate quality assurance and common sense. Int J Radiat Oncol Biol Phys. 2003;57:1210–1213[Editorial]
  55. Lövey K, Fodor J, Major T, et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy – 4-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:724–731
  56. Elkhuizen PHM, Van der Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therapy for invasive breastcancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys. 1998;40:859–867
  57. De la Rochefordiere A, Asselain B, Campana F, et al. Age as a prognostic factor in premenopausal breast carcinoma. Lancet. 1993;341:1039–1043
  58. Polgár C, Fodor J, Major T, et al. The role of boost irradiation in the conservative treatment of stage I–II breast cancer. Pathol Oncol Res. 2001;7:241–250
  59. Polgár C, Fodor J, Orosz Z, et al. Electron and high dose rate brachytherapy boost in the conservative treatment of stage I–II breast cancer: first results of the randomized Budapest boost trial. Strahlenther Onkol. 2002;178:615–623
  60. Polgár C, Fodor J, Orosz Z, et al. Electron and brachytherapy boost in the conservative treatment of stage I–II breast cancer: 5-year results of the randomized Budapest boost trial. Radiother Oncol. 2002;64:S15;[Abstract]
  61. Ashikar R, Huvos A, Urban J, et al. Infiltrating lobular carcinoma of the breast. Cancer. 1973;31:110–116
  62. Fodor J, Major T, Polgár C, et al. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy. Neoplasma. 2000;47:181–186
  63. Fodor J, Sulyok Z, Polgár C, et al. Breast-conserving treatment for early invasive lobular cancer. Magyar Sebészet. 2001;54:209–214[In Hungarian]
  64. Holland PA, Shah A, Howell A, et al. Lobular carcinoma of the breast can be managed by breast conserving therapy. Br J Surg. 1995;82:1364–1366
  65. Morrow M, Keeney K, Scholtens D. Selecting patients for breast-conserving therapy. The importance of lobular histology. Cancer. 2006;106:2563–2568
  66. Peiro G, Bornstein BA, Conolly JL, et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000;59:49–54
  67. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113–120
  68. Schnitt SJ, Conolly JL, Recht A, et al. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 1989;64:448–454
  69. Silverstein MJ, Lewinsky B, Waisman JR, et al. Infiltrating lobular carcinoma: is it different from infiltrating duct carcinoma?. Cancer. 1994;73:1673–1677
  70. Warneke J, Berger R, Johnson C, et al. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg. 1996;172:496–500
  71. Weiss MC, Fowble BL, Solin LJ, et al. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23:941–947
  72. Holland R, Veling SHJ, Mravunac M, et al. Histologic multifocality of Tis, T1–2 breast carcinomas: Implication for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–990
  73. Rakovitch E, Pignol JP, Hanna W, et al. Significance of multifocality in ductal carcinoma in situ: outcome of women treated with breast-conserving therapy. J Clin Oncol. 2007;25:5591–5596
  74. Faverly D, Burgers L, Bult P, et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994;1:193–198
  75. van Limbergen E, Holland R. Patient selection criteria and pathological considerations. In:  Strnad V,  Ott O editor. Partial breast irradiation using multicatheter brachytherapy. Germany: W. Zuckschwerdt Verlag; 2006;p. 15–27
  76. Nelson JC, Beitsch PD, Vicini FA, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg. 2009;198:83–91
  77. Eberlein TJ, Connoly JL, Schnitt SJ, et al. Predictors of local recurrence following conservative breast surgery and radiation therapy. Arch Surg. 1990;125:771–777
  78. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456–1461
  79. Patel R, Ringwala S, Forouzannia A, et al. Clinical fat necrosis in patients treated with multi-catheter APBI: a 3D CT-based clinical correlation. Int J Radiat Oncol Biol Phys. 2007;69:S217;[Abstract]
  80. Wazer DE, Kaufman S, Cuttino L, et al. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–495
  81. Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2001;50:107–111
  82. Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 1993;218:22–28
  83. DiBiase SJ, Komarnicky LT, Schwartz GF, et al. The number of positive margins influences the outcome of women treated breast preservation for early stage breast carcinoma. Cancer. 1998;82:2212–2220
  84. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74:1746–1751
  85. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer. 1995;76:259–267
  86. Spivack B, Khanna MM, Tafra L, et al. Margin status and local recurrence after breast-conserving surgery. Arch Surg. 1994;129:952–957
  87. Holland R, Conolly J, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990;8:113–118
  88. Wazer DE, Kramer B, Schmid C, et al. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys. 1997;39:381–393
  89. Fowble BL, Soin LJ, Schultz DJ, et al. Ten year results of conservative surgery and irradiation for stages I and II breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:269–277
  90. Krishnan L, Jewell WR, Krishnan EC, et al. Breast cancer with extensive intraductal component: treatment with immediate interstitial boost irradiation. Radiology. 1992;183:273–276
  91. Haffty BG. Molecular and genetic markers in the loco-regional treatment of breast cancer. Semin Radiat Oncol. 2002;12:329–340
  92. Sundquist M, Thorstenson S, Klintenberg C, et al. Indicators of loco-regional recurrence in breast cancer: the South East Swedish Breast Cancer Group. Eur J Surg Oncol. 2000;26:357–362
  93. Zellars RC, Hilsenbeck SG, Clark GM, et al. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients. J Clin Oncol. 1996;18:1906–1913
  94. Fisher BJ, Perera FE, Cooke AL, et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence. Int J Radiat Oncol Biol Phys. 1998;42:117–123
  95. Silvestrini R, Daidone MG, Luisi A, et al. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J Clin Oncol. 1995;13:697–704
  96. Elkhuizen PH, Voogd AC, van den Broek LC, et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys. 1999;45:73–83
  97. Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early stage invasive cancer. Acta Oncol. 1999;38:9–17
  98. Recht A. Selection of patients with early stage invasive breast cancer for treatment with conservative surgery and radiation therapy. Semin Oncol. 1996;23:19–30
  99. Borger J, Kempreman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol. 1994;12:653–660
  100. Clemente CG, Boracchi P, Del Vecchio M, et al. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer. 1992;69:1396–1403
  101. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences int he extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087–106.

PII: S0167-8140(10)00066-6

doi: 10.1016/j.radonc.2010.01.014

Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 264-273 , March 2010

Article Tools